The UCSC Xena platform for public and private cancer genomics data visualization and interpretation

Published on Sep 26, 2019in bioRxiv
· DOI :10.1101/326470
Mary Goldman20
Estimated H-index: 20
(UCSC: University of California, Santa Cruz),
Brian Craft19
Estimated H-index: 19
(UCSC: University of California, Santa Cruz)
+ 9 AuthorsDavid Haussler177
Estimated H-index: 177
(UCSC: University of California, Santa Cruz)
UCSC Xena is a visual exploration resource for both public and private omics data, supported through the web-based Xena Browser and multiple turn-key Xena Hubs. This unique archecture allows researchers to view their own data securely, using private Xena Hubs, simultaneously visualizing large public cancer genomics datasets, including TCGA and the GDC. Data integration occurs only within the Xena Browser, keeping private data private. Xena supports virtually any functional genomics data, including SNVs, INDELs, large structural variants, CNV, expression, DNA methylation, ATAC-seq signals, and phenotypic annotations. Browser features include the Visual Spreadsheet, survival analyses, powerful filtering and subgrouping, statistical analyses, genomic signatures, and bookmarks. Xena differentiates itself from other genomics tools, including its predecessor, the UCSC Cancer Genomics Browser, by its ability to easily and securely view public and private data, its high performance, its broad data type support, and many unique features.
📖 Papers frequently viewed together
6 Authors (Mary Goldman, ..., David Haussler)
284 Citations
6,924 Citations
336 Authors (John N. Weinstein, ..., Teresia Kling)
3,713 Citations
#1Marc Streit (Johannes Kepler University of Linz)H-Index: 22
#2Samuel Gratzl (Johannes Kepler University of Linz)H-Index: 10
Last. Christian Haslinger (Boehringer Ingelheim)H-Index: 14
view all 6 authors...
SUMMARY: Ordino is a web-based analysis tool for cancer genomics that allows users to flexibly rank, filter and explore genes, cell lines and tissue samples based on pre-loaded data, including The Cancer Genome Atlas, the Cancer Cell Line Encyclopedia and manually uploaded information. Interactive tabular data visualization that facilitates the user-driven prioritization process forms a core component of Ordino. Detail views of selected items complement the exploration. Findings can be stored, s...
9 CitationsSource
#1M. Ryan Corces (Stanford University)H-Index: 21
#2Jeffrey M. Granja (Stanford University)H-Index: 17
Last. Howard Y. ChangH-Index: 119
view all 24 authors...
INTRODUCTION Cancer is one of the leading causes of death worldwide. Although the 2% of the human genome that encodes proteins has been extensively studied, much remains to be learned about the noncoding genome and gene regulation in cancer. Genes are turned on and off in the proper cell types and cell states by transcription factor (TF) proteins acting on DNA regulatory elements that are scattered over the vast noncoding genome and exert long-range influences. The Cancer Genome Atlas (TCGA) is ...
369 CitationsSource
#1Li DingH-Index: 113
#2Matthew H. Bailey (WashU: Washington University in St. Louis)H-Index: 15
Last. Armaz MariamidzeH-Index: 8
view all 34 authors...
The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of diverse genomic alterations underlying human cancers. At this historic junction marking the completion of genomic characterization of over 11,000 tumors from 33 cancer types, we present our current understanding of the molecular processes governing oncogenesis. We illustrate our insights into cancer through synthesis of the findings of the TCGA PanCancer Atlas project on three facets of oncogenesis: (1) somatic driver mu...
155 CitationsSource
#1Katherine A. Hoadley (UNC: University of North Carolina at Chapel Hill)H-Index: 8
#1Katherine A. Hoadley (UNC: University of North Carolina at Chapel Hill)H-Index: 64
Last. Christopher C. Benz (Buck Institute for Research on Aging)H-Index: 84
view all 23 authors...
We conducted comprehensive integrative molecular analyses of the complete set of tumors in The Cancer Genome Atlas (TCGA), consisting of approximately 10,000 specimens and representing 33 types of cancer. We performed molecular clustering using data on chromosome-arm-level aneuploidy, DNA hypermethylation, mRNA, and miRNA expression levels and reverse-phase protein arrays, of which all, except for aneuploidy, revealed clustering primarily organized by histology, tissue type, or anatomic origin. ...
799 CitationsSource
#1Tathiane M. Malta (USP: University of São Paulo)H-Index: 13
#2Artem Sokolov (Harvard University)H-Index: 21
Last. Maciej WiznerowiczH-Index: 30
view all 23 authors...
Cancer progression involves the gradual loss of a differentiated phenotype and acquisition of progenitor and stem-cell-like features. Here, we provide novel stemness indices for assessing the degree of oncogenic dedifferentiation. We used an innovative one-class logistic regression (OCLR) machine-learning algorithm to extract transcriptomic and epigenetic feature sets derived from non-transformed pluripotent stem cells and their differentiated progeny. Using OCLR, we were able to identify previo...
385 CitationsSource
#1Francisco Sanchez-Vega (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 33
#2Marco Mina (Swiss Institute of Bioinformatics)H-Index: 18
Last. Giovanni Ciriello (Swiss Institute of Bioinformatics)H-Index: 42
view all 54 authors...
Summary Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-occurrence of alterations in these pathways differ between individual tumors and tumor types. Using mutations, copy-number changes, mRNA expression, gene fusions and DNA methylation in 9,125 tumors profiled by The Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic alterations in ten canonic...
889 CitationsSource
#1Qingsong Gao (WashU: Washington University in St. Louis)H-Index: 12
#2Wen-Wei Liang (WashU: Washington University in St. Louis)H-Index: 7
Last. Ilya ShmulevichH-Index: 10
view all 22 authors...
Gene fusions represent an important class of somatic alterations in cancer. We systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple fusion calling tools. We identified a total of 25,664 fusions, with a 63% validation rate. Integration of gene expression, copy number, and fusion annotation data revealed that fusions involving oncogenes tend to exhibit increased expression, whereas fusions involving tumor suppressors have the opposite effect. For fusions involv...
209 CitationsSource
#1Wanding Zhou (Van Andel Institute)H-Index: 26
#2Huy Q. Dinh (Cedars-Sinai Medical Center)H-Index: 20
Last. Benjamin P. Berman (Cedars-Sinai Medical Center)H-Index: 48
view all 8 authors...
DNA methylation loss occurs frequently in cancer genomes, primarily within lamina-associated, late-replicating regions termed partially methylated domains (PMDs). We profiled 39 diverse primary tumors and 8 matched adjacent tissues using whole-genome bisulfite sequencing (WGBS) and analyzed them alongside 343 additional human and 206 mouse WGBS datasets. We identified a local CpG sequence context associated with preferential hypomethylation in PMDs. Analysis of CpGs in this context (‘solo-WCGWs’...
118 CitationsSource
#1Xiaotu Ma (St. Jude Children's Research Hospital)H-Index: 23
#2Yu Liu (St. Jude Children's Research Hospital)H-Index: 63
Last. Jinghui ZhangH-Index: 86
view all 33 authors...
Analysis of the genomes, exomes and transcriptomes of 1,699 childhood cancers identifies 142 driver genes.
298 CitationsSource
#1Marcin Cieślik (UM: University of Michigan)H-Index: 12
#2Arul M. ChinnaiyanH-Index: 160
Although cancer genome sequencing is becoming routine in cancer research, cancer transcriptome profiling through methods such as RNA sequencing (RNA-seq) provides information not only on mutations but also on their functional cellular consequences. This Review discusses how technical and analytical advances in cancer transcriptomics have provided various clinically valuable insights into gene expression signatures, driver gene prioritization, cancer microenvironments, immuno-oncology and prognos...
105 CitationsSource
Cited By257
#2Wenbin LiangH-Index: 2
Last. Xianchun ZouH-Index: 3
view all 0 authors...
#1R. SunH-Index: 1
#2Lixiazi He (Molecular Medicine Partnership Unit)
Last. Christof NiehrsH-Index: 79
view all 0 authors...
Acute myeloid leukemia (AML) is a rapidly progressing cancer, for which chemotherapy remains standard treatment and additional therapeutic targets are requisite. Here, we show that AML cells secrete the stem cell growth factor R-spondin 2 (RSPO2) to promote their self-renewal and prevent cell differentiation. Although RSPO2 is a well-known WNT agonist, we reveal that it maintains AML self-renewal WNT independently, by inhibiting BMP receptor signaling. Autocrine RSPO2 signaling is also required ...
#1Chloe Maurizy (CNRS: Centre national de la recherche scientifique)
#2Claire Abeza (CNRS: Centre national de la recherche scientifique)H-Index: 2
Last. Francina Langa (Pasteur Institute)H-Index: 16
view all 19 authors...
The R2TP chaperone cooperates with HSP90 to integrate newly synthesized proteins into multi-subunit complexes, yet its role in tissue homeostasis is unknown. Here, we generated conditional, inducible knock-out mice for Rpap3 to inactivate this core component of R2TP in the intestinal epithelium. In adult mice, Rpap3 invalidation caused destruction of the small intestinal epithelium and death within 10 days. Levels of R2TP substrates decreased, with strong effects on mTOR, ATM and ATR. Proliferat...
#1Abdullah Al Mamun (FIU: Florida International University)H-Index: 7
#2Raihanul Bari Tanvir (FIU: Florida International University)H-Index: 4
Last. Ananda Mohan Mondal (FIU: Florida International University)H-Index: 5
view all 7 authors...
Long non-coding RNA plays a vital role in changing the expression profiles of various target genes that leads to cancer development. Thus, identifying prognostic lncRNAs related to different cancers might help in developing cancer therapy. To discover the critical lncRNAs that can identify the origin of different cancers, we proposed to use the state-of-the-art deep learning algorithm Concrete Autoencoder (CAE) in an unsupervised setting, which efficiently identifies a subset of the most informa...
#1Fei Zhao (Mayo Clinic)H-Index: 7
#2Wootae Kim (Mayo Clinic)H-Index: 6
Last. Qi Hu (Mayo Clinic)H-Index: 6
view all 24 authors...
The shieldin complex functions as the downstream effector of 53BP1-RIF1 to promote DNA double-strand break end-joining by restricting end resection. The SHLD2 subunit binds to single-stranded DNA ends and blocks end resection through OB-fold domains. Besides blocking end resection, it is unclear how the shieldin complex processes SHLD2-bound single-stranded DNA and promotes non-homologous end-joining. Here, we identify a downstream effector of the shieldin complex, ASTE1, as a structure-specific...
2 CitationsSource
#1Hao Jiang (THU: Tsinghua University)
#2Hongquan Zhang (PKU: Peking University)H-Index: 30
Last. Xuegong Zhang (THU: Tsinghua University)H-Index: 48
view all 3 authors...
Colorectal cancer (CRC) progression is associated with cancer cell dedifferentiation and sternness acquisition. Several methods have been developed to identify sternness signatures in CRCs. However, studies that directly measured the degree of dedifferentiation in CRC tissues are limited. It is unclear how the differentiation states change during CRC progression. To address this, we develop a method to analyze the tissue differentiation spectrum in colorectal cancer using normal gastrointestinal...
#1Jialiang Shao (SJTU: Shanghai Jiao Tong University)H-Index: 2
#2Tiezhu Shi (SJTU: Shanghai Jiao Tong University)
Last. Xiongjun Wang (GU: Guangzhou University)
view all 7 authors...
The mTORC1 pathway plays key roles in regulating various biological processes, including sensing amino acid deprivation and driving expression of ribosomal protein (RP)-coding genes. In this study, we observed that depletion of glutamate dehydrogenase 1 (GDH1), an enzyme that converts glutamate to α-ketoglutarate (αKG), confers resistance to amino acid deprivation on kidney renal clear cell carcinoma (KIRC) cells. Mechanistically, under conditions of adequate nutrition, GDH1 maintains RP gene ex...
With the development of high-throughput sequencing technology, a huge amount of multi-omics data has been accumulated. Although there are many software tools for statistical analysis and visual development of omics data, these tools are not suitable for private data and non-technical users. Besides, most of these tools have specialized in only one or perhaps a few data typesare, without combining clinical information. What’s more, users could not choose data processing and model selection flexib...
#1Mara ArtibaniH-Index: 7
#2Kenta Masuda (University of Oxford)H-Index: 22
Last. Ahmed Ashour AhmedH-Index: 28
view all 31 authors...
Similar to tumor initiating cells (TICs), minimal residual disease (MRD) is capable of re-initiating tumors and causing recurrence. However, the molecular characteristics of solid tumor MRD cells and drivers of their survival have remained elusive. Here we performed dense multi-region transcriptomics analysis of paired biopsies from 17 ovarian cancer patients before and after chemotherapy. We reveal that while MRD cells share important molecular signatures with TICs, they are also characterized ...
#1Wei Huff (IU: Indiana University)
#2Marpe Bam (UW: University of Wisconsin-Madison)H-Index: 2
Last. Jack M. Shireman (UW: University of Wisconsin-Madison)H-Index: 1
view all 15 authors...
Clinical use of various forms of immunotherapeutic drugs in glioblastoma (GBM), has highlighted severe T cell dysfunction such as exhaustion in GBM patients. However, reversing T cell exhaustion using immune checkpoint inhibitors in GBM clinical trials has not shown significant overall survival benefit. Phenotypically, CD8+ T cells with downregulated CD28 coreceptors, low CD27 expression, increased CD57 expression, and telomere shortening are classified as senescent T cells. These senescent T ce...